Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 19/20 | 0.39 |
| ▸ | PPARA | Q07869 | 11/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2656087 | 0.92 | GRIA4 (0.39) | PPARDPPARAALDH1A1 | |
| SCHEMBL2655773 | 0.90 | PPARD (0.38) | PPARDPPARAPPARG | |
| SCHEMBL2661637 | 0.86 | MCL1 (0.43) | PPARDPPARAPPARGNPC1ALDH1A1 | |
| SCHEMBL2653312 | 0.83 | MAPT (0.36) | PPARDPPARAPPARGNPC1ALDH1A1 | |
| SCHEMBL2652568 | 0.83 | PPARD (0.40) | PPARDPPARAPPARG | |
| SCHEMBL2655627 | 0.82 | PPARD (0.39) | PPARDPPARAPPARGALDH1A1 | |
| SCHEMBL2658618 | 0.82 | GRIA4 (0.37) | PPARDPPARAALDH1A1 | |
| SCHEMBL2655215 | 0.81 | PPARD (0.39) | PPARDPPARAPPARGALDH1A1 | |
| SCHEMBL2655360 | 0.81 | PPARD (0.43) | PPARDPPARAPPARG | |
| SCHEMBL2656753 | 0.80 | PPARD (0.42) | PPARDPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1957484-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | Eli Lilly & Company (US) | 2008-08-20 | — | — | EP | claimed |
| WO-2007120284-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-10-25 | — | — | WO | claimed |
| EP-1957484-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | Eli Lilly & Company (US) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007120284-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-10-25 | — | — | WO | disclosed |